I don't think there is any perceived criticism of the current board / MD newcomers , their competence or indeed their character or motivations , at least not from this poster.
However , there is a deep concern by many (and rightly so imo) as to how a project could get to the stage that it did with (what is now reported in the AGM Presentation) such glaring deficiencies across so many Critical Path areas/items of the schedule. Any one or two of them should have flagged a high or extreme risk in any risk analysis.
The combination of them all was obviously the perfect storm for a "show stopper".
Full points to the current MD and board for finally enlightening us to the previous "high risk" deficiencies that existed in the original program critical path . As also mentioned I look forward to the current MD and board addressing these issues in a conventional methodical manner with all appropriate checks and balances in order to get the LGP off the ground.
My opinion only , so DYOR.
- Forums
- ASX - By Stock
- KIN
- Ann: Exploration Update
Ann: Exploration Update, page-22
Featured News
Add KIN (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
-0.001(1.82%) |
Mkt cap ! $63.62M |
Open | High | Low | Value | Volume |
5.5¢ | 5.5¢ | 5.3¢ | $66.71K | 1.252M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 105989 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 181818 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 105989 | 0.054 |
1 | 383484 | 0.053 |
4 | 303282 | 0.052 |
3 | 85000 | 0.051 |
5 | 850000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 181818 | 1 |
0.058 | 249798 | 2 |
0.059 | 250000 | 1 |
0.060 | 155989 | 2 |
0.062 | 48000 | 1 |
Last trade - 15.31pm 03/07/2024 (20 minute delay) ? |
Featured News
KIN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online